Connecting With Neurology Patients Through Music
An interview with a neurologist who found that merely writing medical articles cannot express the impact an illness can have on patients, both literally and emotionally.
Phase 2 Trial for Angelman Syndrome Underway
In this podcast, Heidi Moawad, MD interviews Cesar Ochoa-Lubinoff, MD, MPH, FAAP, about recent encouraging clinical trial results in patients with Angelman syndrome.
Benefits of Martial Arts on Movement Disorders
This podcast discusses preliminary evidence about the effects of karate on quality of life and several measures of gait, balance, and mobility in patients with PD.
A Patient With Medication-Resistant Atrial Fibrillation and Autonomic Dysfunction
A patient with worsening atrial fibrillation experiences improvement of his symptoms and heart rate with chiropractic manipulation. More in this podcast.
Integrative Health and Parkinson Disease
It has been estimated that between 40% and 60% of patients with PD use at least one form of complementary medicine. In this podcast, neurologist Sarah Mulukutla, MD, MPH talks about CAM options for neurologists to discuss with their patients.
Exploring the Impact of Language Barriers on Stroke Care
The importance of effective communication and cultural awareness in patient care and outcomes cannot be overstated.
Clinical Study Looks at DBS for Impulsivity in Parkinson
Dr. Abhinav Raina presents his research on the effect of subthalamic nucleus deep brain stimulation on impulsivity in Parkinson disease patients.
Curious Results in Myasthenia Gravis Study
An expert presents the results of a phase 2 study on the impact of rituximab on myasthenia gravis.
Significant Improvement Found in Clinical Trial for Dravet Syndrome
An expert describes the efficacy of fenfluramine in decreasing seizure frequency associated with this rare syndrome.
A Challenging Case: Carbon Monoxide Poisoning and Parkinsonian Symptoms
A unique case of chronic, low level carbon monoxide poisoning in a car mechanic that resulted in Parkinsonian symptoms.
Epigenetics and Alzheimer Risk
What does epigenetics have to do with risk for Alzheimer disease? Are our epigenetics immutable? What are the therapeutic implications? Those questions answered in this podcast.
Alzheimer Disease: New Drugs in the Offing?
What medications are in the pipeline that may help slow or even prevent the development of Alzheimer disease?
5 Neuroprotective Strategies to Reduce Brain Injury
An expert discusses the latest guidelines to reduce brain injury in adults who are comatose after cardiac resuscitation.
Responsive Neurostimulation: 5 Important Facts
Key details about an option for the treatment of drug-resistant epilepsy in patients who are not surgical candidates.
Early Life Matters in Very Late Life
Alzheimer disease is not an equal opportunity employer. Insights about early life stressors and economic disadvantage.
5 Important Facts About SUDEP
What do the new AAN guidelines on SUDEP offer? Here’s a quick overview of the key facts.
Epilepsy: More Common Than You Thought
The largest study of its kind shows that 8 in 1000 people have epilepsy--a distinctly higher incidence than previously thought. Details and implications in this podcast.
Migraine and Parkinson Disease: New Study Finds a Link
In this podcast, Ann Scher, PhD, lead author in a recently published study, gives a succinct overview of the details and briefly discusses what the findings may suggest.
Epilepsy and Comorbidities: Clinical and Cost Implications
Persons with epilepsy have a higher prevalence of comorbid conditions-psychiatric disorders in particular-than the general population.
2 Clarke Drive Cranbury, NJ 08512